BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36527302)

  • 1. Heart transplantation in the era of corona virus disease 2019: Impact of the pandemic on donors, recipients and outcome.
    Immohr MB; Ballazs C; Hettlich V; Scheiber D; Bönner F; Westenfeld R; Aubin H; Tudorache I; Akhyari P; Lichtenberg A; Boeken U
    Clin Transplant; 2023 Apr; 37(4):e14887. PubMed ID: 36527302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.
    Han J; Moayedi Y; Yang W; Henricksen EJ; Lee R; Purewal S; Chang E; Duclos S; Lyapin A; Feng K; Hiesinger W; Teuteberg JJ; Khush KK
    J Heart Lung Transplant; 2022 Feb; 41(2):237-243. PubMed ID: 34815161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
    Fudim M; Davis ME; Jenkins C; Brown CL; Wigger MA; Stulak JM; Maltais S; Haglund N
    Ann Thorac Surg; 2015 Dec; 100(6):2117-25; discussion 2125-6. PubMed ID: 26338051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor variables on heart transplantation outcomes in mechanically bridged versus standard recipients†.
    Urban M; Booth K; Jungschleger J; Netuka I; Schueler S; MacGowan G
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):455-464. PubMed ID: 30169835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.
    Oehler D; Bruno RR; Boeken U; Westenfeld R
    Transpl Infect Dis; 2021 Aug; 23(4):e13681. PubMed ID: 34216078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cardiac arrest resuscitated donors on heart transplant recipients' outcome.
    Galeone A; Varnous S; Lebreton G; Barreda E; Hariri S; Pavie A; Leprince P
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):622-630. PubMed ID: 27938903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device as bridge to heart transplantation--lessons learned with the MicroMed DeBakey axial blood flow pump.
    Salzberg S; Lachat M; Zünd G; Oechslin E; Schmid ER; DeBakey M; Turina M
    Eur J Cardiothorac Surg; 2003 Jul; 24(1):113-8. PubMed ID: 12853054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart transplantation from donors with left ventricular ejection fraction under forty percent.
    Poptsov V; Khatutskiy V; Skokova A; Krasivskyi I; Sabashnikov A; Merkle-Storms J; Spirina E
    Clin Transplant; 2021 Jul; 35(7):e14341. PubMed ID: 33949006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donors' characteristics and impact on outcomes in pediatric heart transplant recipients.
    Conway J; Chin C; Kemna M; Burch M; Barnes A; Tresler M; Scheel JN; Naftel DC; Beddow K; Allain-Rooney T; Dipchand AI;
    Pediatr Transplant; 2013 Dec; 17(8):774-81. PubMed ID: 24102961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-term results of heart transplantation using donors over 63 years of age.
    Potapov EV; Loebe M; Hübler M; Musci M; Hummel M; Weng Y; Hetzer R
    Transplantation; 1999 Dec; 68(12):1834-8. PubMed ID: 10628759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Therapeutic Modification on Outcomes in Heart Transplantation Over the Past Two Decades - A Single-Center Experience in Japan.
    Yanase M; Iwasaki K; Watanabe T; Seguchi O; Nakajima S; Kuroda K; Mochizuki H; Matsuda S; Takenaka H; Ikura M; Tadokoro N; Fukushima S; Fujita T; Ishibashi-Ueda H; Nakatani T; Kitamura S; Kobayashi J; Tsujita K; Ogawa H; Fukushima N
    Circ J; 2020 May; 84(6):965-974. PubMed ID: 32350231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical circulatory support and heart transplantation: donor and recipient factors influencing graft survival.
    Maltais S; Jaik NP; Feurer ID; Wigger MA; DiSalvo TG; Schlendorf KH; Ahmad RM; Lenihan DJ; Stulak JM; Keebler ME
    Ann Thorac Surg; 2013 Oct; 96(4):1252-1258. PubMed ID: 23915592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pretransplant left ventricular assist device support duration on outcome after heart transplantation.
    Immohr MB; Aubin H; Erbel-Khurtsidze S; Dalyanoglu H; Bruno RR; Westenfeld R; Tudorache I; Akhyari P; Boeken U; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2022 Feb; 34(3):462-469. PubMed ID: 34647129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.